These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 6135958)

  • 1. Focal changes in Alzheimer's disease and cholinergic hypothesis.
    Rossor MN
    Lancet; 1983 Aug; 2(8347):465. PubMed ID: 6135958
    [No Abstract]   [Full Text] [Related]  

  • 2. Neuroanatomical evidence for a cholinergic deficit in Alzheimer's disease.
    Whitehouse PJ; Struble RG; Hedreen JC; Clark AW; White CL; Parhad IM; Price DL
    Psychopharmacol Bull; 1983; 19(3):437-40. PubMed ID: 6635120
    [No Abstract]   [Full Text] [Related]  

  • 3. Biochemical pathology and treatment strategies in Alzheimer's disease: emphasis on the cholinergic system.
    Winblad B; Messamore E; O'Neill C; Cowburn R
    Acta Neurol Scand Suppl; 1993; 149():4-6. PubMed ID: 8128837
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Alzheimer-type dementia. Possible relation to hypofunction of the cholinergic central nervous system].
    Mellgren SI
    Tidsskr Nor Laegeforen; 1980 Aug; 100(23):1355-6. PubMed ID: 7456014
    [No Abstract]   [Full Text] [Related]  

  • 5. [Neurotransmitter anomalies in Alzheimer's disease].
    Berger B
    Rev Neurol (Paris); 1984; 140(10):539-52. PubMed ID: 6150545
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo mapping of cholinergic terminals in normal aging, Alzheimer's disease, and Parkinson's disease.
    Kuhl DE; Minoshima S; Fessler JA; Frey KA; Foster NL; Ficaro EP; Wieland DM; Koeppe RA
    Ann Neurol; 1996 Sep; 40(3):399-410. PubMed ID: 8797529
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The EEG as an indicator of cholinergic deficit in Alzheimer's disease].
    Adler G
    Fortschr Neurol Psychiatr; 2000 Aug; 68(8):352-6. PubMed ID: 11006862
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Alzheimer's disease: from neuropathology to symptoms].
    Hauw JJ; Duyckaerts C; Delaère P; Lamy C
    Rev Prat; 1991 May; 41(13):1188-94. PubMed ID: 2063122
    [No Abstract]   [Full Text] [Related]  

  • 9. Cytoarchitectonics of some areas of the human cerebral cortex in Alzheimer's disease and senile dementia.
    Bogolepova IN
    Neurosci Behav Physiol; 1989; 19(6):493-8. PubMed ID: 2615964
    [No Abstract]   [Full Text] [Related]  

  • 10. Dementia without cholinergic deficit.
    Riekkinen PJ; Soininen H; Sirviö J; Reinikainen K; Helkala EL; Paljärvi L
    Gerontology; 1987; 33(3-4):268-72. PubMed ID: 3653707
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Relation between the degree of severity of the dementia and the extent of the manifestation of the pathomorphological changes in the cerebral cortex in senile dementia and Alzheimer's disease].
    Shefer VF
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1984; 84(7):1004-6. PubMed ID: 6475406
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased mydriatic response to tropicamide is a sign of cholinergic hypersensitivity but not specific to late-onset sporadic type of Alzheimer's dementia.
    Kálmán J; Kanka A; Maglóczky E; Szóke A; Járdánházy T; Janka Z
    Biol Psychiatry; 1997 Apr; 41(8):909-11. PubMed ID: 9099419
    [No Abstract]   [Full Text] [Related]  

  • 13. A quantitative study of the cerebral cortex in Alzheimer's disease and senile dementia using an automatic image analyzing system.
    Sauer B; Dietl HW; Kretschmann HJ; Mehraein P
    J Hirnforsch; 1986; 27(6):695-702. PubMed ID: 3571965
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cytoarchitectonic characteristics of the fields of the human cerebral cortex in Alzheimer's disease and senile dementia].
    Bogolepova IN
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1988; 88(7):39-44. PubMed ID: 3188773
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New insights into Alzheimer's disease.
    Habeck M
    Drug Discov Today; 2002 Apr; 7(8):441-2. PubMed ID: 11965384
    [No Abstract]   [Full Text] [Related]  

  • 16. Alzheimer's disease.
    Somasundaram O
    J Indian Med Assoc; 1974 Jul; 63(2):66-8. PubMed ID: 4436559
    [No Abstract]   [Full Text] [Related]  

  • 17. Cognitive deficits in olivopontocerebellar atrophy: implications for the cholinergic hypothesis of Alzheimer's dementia.
    Kish SJ; el-Awar M; Schut L; Leach L; Oscar-Berman M; Freedman M
    Ann Neurol; 1988 Aug; 24(2):200-6. PubMed ID: 3178175
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Scopolamine challenges in Alzheimer's disease.
    Sunderland T; Tariot P; Murphy DL; Weingartner H; Mueller EA; Cohen RM
    Psychopharmacology (Berl); 1985; 87(2):247-9. PubMed ID: 3931154
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serotonin nerve cells in Alzheimer's disease.
    Mann DM; Yates PO
    J Neurol Neurosurg Psychiatry; 1983 Jan; 46(1):96. PubMed ID: 6842210
    [No Abstract]   [Full Text] [Related]  

  • 20. Neocortical morphometry and cholinergic neurochemistry in Pick's disease.
    Hansen LA; Deteresa R; Tobias H; Alford M; Terry RD
    Am J Pathol; 1988 Jun; 131(3):507-18. PubMed ID: 3381880
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.